Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bharat ParenteralsBOM:541096 +6.14%72 Days Inventory is 166.91 as of Jun. 2026, which is 154% above its 10-year median of 65.66. GuruFocus rates BOM:541096 with a GF Score™ of 72/100 and a GF Value™ of ₹1,220.25 (Fairly Valued). The stock has 7 warning signs investors should review. Among 918 Drug Manufacturers companies, Bharat Parenterals ranks worse than 52.51% on this metric.
The historical rank and industry rank for Bharat Parenterals's Days Inventory or its related term are showing as below:
BOM:541096'
s Days Inventory Range Over the Past 10 Years
Min: 46.21 Med: 65.66 Max: 170.15
Current: 170.15
During the past 13 years, Bharat Parenterals's highest Days Inventory was 170.15. The lowest was 46.21. And the median was 65.66.
BOM:541096's Days Inventory is ranked worse than 52.51% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.8
vs BOM:541096: 170.15
Bharat Parenterals's Days Inventory
increased
from Jun. 2025 (95.36) to Jun. 2026 (166.91).
It might indicate that Bharat Parenterals's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bharat Parenterals's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.55.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bharat Parenterals's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.90.
Bharat Parenterals (BOM:541096) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bharat Parenterals's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bharat Parenterals's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bharat Parenterals Days Inventory Related Terms
Bharat Parenterals Days Inventory Historical Data
* Premium members only.
The historical data trend for Bharat Parenterals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bharat Parenterals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bharat Parenterals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bharat Parenterals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bharat Parenterals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bharat Parenterals (BOM:541096) has a Days Inventory of 166.91 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bharat Parenterals and its competitors. This is 154% above median its historical median of 65.66. Over the past decade, Bharat Parenterals' Days Inventory has ranged from 46.21 to 170.15. According to the industry distribution chart, Bharat Parenterals ranks #482 out of 918 companies in the Drug Manufacturers industry, placing it in the top 52.5%.
Is Bharat Parenterals' Days Inventory too high?
Bharat Parenterals' current Days Inventory of 166.91 is 154% above median its 10-year median of 65.66. Over the past 10 years, this metric has ranged from a low of 46.21 to a high of 170.15. The Drug Manufacturers industry median Days Inventory is 164.80. Bharat Parenterals' value of 166.91 is 1.3% above this industry median. Based on the distribution chart, Bharat Parenterals ranks #482 out of 918 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bharat Parenterals has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bharat Parenterals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bharat Parenterals ranks #482 out of 918 companies for Days Inventory. This places Bharat Parenterals in the lower half of its industry. The industry median Days Inventory is 164.80. Bharat Parenterals' value of 166.91 is 1.3% above this benchmark. Historically, Bharat Parenterals' own Days Inventory has ranged from 46.21 to 170.15 over the past decade. While the company's 10-year median is 65.66 vs. the industry median of 164.80, Bharat Parenterals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.80, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bharat Parenterals's current Days Inventory of 166.91 is 1.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bharat Parenterals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bharat Parenterals's current Days Inventory is 166.91, which is 154% above median its own 10-year median of 65.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Parenterals stock overvalued right now?
Based on GuruFocus' analysis, Bharat Parenterals (BOM:541096) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,220.25, compared to a current price of ₹1,339.00 — trading 9.7% above its estimated fair value. The current Days Inventory is 166.91, which is 154% above median its 10-year median of 65.66 and 1.3% above the Drug Manufacturers industry median of 164.80. Bharat Parenterals' overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bharat Parenterals (BOM:541096), the current Days Inventory is 166.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bharat Parenterals (BOM:541096) Overvalued in 2026?
Based on GuruFocus' analysis, Bharat Parenterals stock appears to be overvalued.
The current stock price of ₹1,339.00 is trading 9.7% above its estimated GF Value™ of ₹1,220.25.
GuruFocus considers Bharat Parenterals to be Fairly Valued.
Key valuation signals for BOM:541096:
Days Inventory: 166.91 (154% above median its 10-year median of 65.66)
GF Value™: ₹1,220.25 vs. price of ₹1,339.00 (9.7% above fair value)
Industry Position: 1.3% above the Drug Manufacturers median (#482 of 918)
No single metric tells the full story. See the BOM:541096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bharat Parenterals Ltd is a pharmaceutical company. It provides various products such as Capsules, Dry Syrups, Sachets, Oral Liquids, Injections, Semisolids, and others. Geographically, the group has a business presence in India and Outside India.
72GF Score
Get the complete analysis for BOM:541096
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:541096 has been successfully added to your 
